Enzyme replacement therapy in Fabry cardiomyopathy: an incomplete treatment

被引:0
|
作者
Nicholls, Kathleen [1 ,2 ]
机构
[1] Royal Melbourne Hosp, Nephrol, Parkville, Vic, Australia
[2] Univ Melbourne Med, Royal Melbourne Hosp, Parkville, Vic, Australia
关键词
genetic diseases; inborn; metabolic diseases; cardiomyopathy; restrictive; CARDIAC INVOLVEMENT; AGALSIDASE-BETA; DISEASE;
D O I
10.1136/heartjnl-2024-324238
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:971 / 971
页数:1
相关论文
共 50 条
  • [1] Progression of Fabry Cardiomyopathy Despite Enzyme Replacement Therapy
    Pieroni, Maurizio
    Camporeale, Antonia
    Della Bona, Roberta
    Sabini, Alessandra
    Cosmi, Deborah
    Magnolfi, Annalisa
    Bolognese, Leonardo
    CIRCULATION, 2013, 128 (15) : 1687 - 1688
  • [2] Paradoxical Response to Enzyme Replacement Therapy of Fabry Disease Cardiomyopathy
    Frustaci, Andrea
    Russo, Matteo A.
    Chimenti, Cristina
    CIRCULATION-CARDIOVASCULAR IMAGING, 2016, 9 (08)
  • [3] Long term effects of enzyme replacement therapy on the fabry cardiomyopathy: the earlier the treatment the better the outcome
    Weidemann, F.
    Niemann, M.
    Breunig, F.
    Herrmann, S.
    Emmert, A.
    Beer, M.
    Voelker, W.
    Ertl, G.
    Wanner, C.
    Strotmann, J.
    EUROPEAN HEART JOURNAL, 2008, 29 : 150 - 150
  • [4] Evaluation of Proinflammatory Prognostic Biomarkers for Fabry Cardiomyopathy With Enzyme Replacement Therapy
    Chen, Kuan-Hsuan
    Chien, Yueh
    Wang, Kang-Ling
    Leu, Hsin-Bang
    Hsiao, Chen-Yuan
    Lai, Ying-Hsiu
    Wang, Chien-Ying
    Chang, Yuh-Lih
    Lin, Shing-Jong
    Niu, Dau-Ming
    Chiou, Shih-Hwa
    Yu, Wen-Chung
    CANADIAN JOURNAL OF CARDIOLOGY, 2016, 32 (10) : 1221.e1 - 1221.e9
  • [5] Cardiomyopathy and Response to Enzyme Replacement Therapy in a Male Mouse Model for Fabry Disease
    Cat, Aurelie Nguyen Dinh
    Escoubet, Brigitte
    Agrapart, Vincent
    Griol-Charhbili, Violaine
    Schoeb, Trenton
    Feng, Wenguang
    Jaimes, Edgar
    Warnock, David G.
    Jaisser, Frederic
    PLOS ONE, 2012, 7 (05):
  • [6] Angiokeratomas and treatment with enzyme replacement therapy in a patient with Fabry disease
    Sabovic, Eva Klara Merzel
    Tansek, Mojca Zerjav
    Groselj, Urh
    Dragos, Vlasta
    ACTA DERMATOVENEROLOGICA ALPINA PANNONICA ET ADRIATICA, 2020, 29 (02): : 89 - 91
  • [7] Long-Term Effects of Enzyme Replacement Therapy on Fabry Cardiomyopathy Evidence for a Better Outcome With Early Treatment
    Weidemann, Frank
    Niemann, Markus
    Breunig, Frank
    Herrmann, Sebastian
    Beer, Meinrad
    Stoerk, Stefan
    Voelker, Wolfram
    Ertl, Georg
    Wanner, Christoph
    Strotmann, Joerg
    CIRCULATION, 2009, 119 (04) : 524 - 529
  • [8] Enzyme replacement therapy in Fabry disease
    Grundmann, F.
    Benzing, T.
    Kurschat, C.
    NEPHROLOGE, 2015, 10 (03): : 207 - 213
  • [9] Fabry disease:: enzyme replacement therapy
    Bongiorno, MR
    Pistone, G
    Aricò, M
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2003, 17 (06) : 676 - 679
  • [10] Enzyme replacement therapy of fabry disease
    Joe T. R. Clarke
    R. Mark Iwanochko
    Molecular Neurobiology, 2005, 32 : 43 - 50